The legacy success of copyright’s flagship drug has undeniably transformed the pharmaceutical landscape. However, wagering in companies heavily dependent on generic versions and the waning patent protection https://kingbookmark.com/story21460117/the-blue-pill-and-pharmaceutical-companies-a-uncertain-opportunity